Your browser doesn't support javascript.
loading
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial.
Zamagni, Elena; Oliva, Stefania; Gay, Francesca; Capra, Andrea; Rota-Scalabrini, Delia; D'Agostino, Mattia; Belotti, Angelo; Galli, Monica; Racca, Manuela; Zambello, Renato; Gamberi, Barbara; Albano, Domenico; Bertamini, Luca; Versari, Annibale; Grasso, Mariella; Sgherza, Nicola; Priola, Claudia; Fioritoni, Francesca; Patriarca, Francesca; De Cicco, Gabriella; Villanova, Tania; Pascarella, Anna; Zucchetta, Pietro; Tacchetti, Paola; Fanti, Stefano; Mancuso, Katia; Barbato, Simona; Boccadoro, Mario; Musto, Pellegrino; Cavo, Michele; Nanni, Cristina.
Afiliação
  • Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
  • Oliva S; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.
  • Gay F; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
  • Capra A; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
  • Rota-Scalabrini D; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • D'Agostino M; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Belotti A; Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO-IRCCS, Torino, Italy.
  • Galli M; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
  • Racca M; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Zambello R; Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Gamberi B; UO Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Albano D; Nuclear Medicine Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
  • Bertamini L; Department of Medicine (DIMED), Hematology and Clinical Immunology, Padua University, Padua, Italy.
  • Versari A; Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Grasso M; Nuclear Medicine Department, University of Brescia and ASST Spedali Civili Brescia, Brescia, Italy.
  • Sgherza N; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
  • Priola C; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Fioritoni F; Nuclear Medicine Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Patriarca F; Azienda Ospedaliera S. Croce-Carle, Cuneo, Italy.
  • De Cicco G; Hematology and Stem Cell Transplantation Unit, AOU Consorziale Policlinico, Bari, Italy.
  • Villanova T; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Pascarella A; Ospedale Santo Spirito, Pescara, Italy.
  • Zucchetta P; Hematologic Clinic and Transplant Center, University Hospital of Central Friuli, DAME, University of Udine, Udine, Italy.
  • Tacchetti P; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
  • Fanti S; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.
  • Mancuso K; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Barbato S; UOC Ematologia, Ospedale dell'Angelo, Venezia Mestre, Italy.
  • Boccadoro M; Nuclear Medicine Unit, Department of Medicine DIMED, University-Hospital of Padova, Padova, Italy.
  • Musto P; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
  • Cavo M; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Nanni C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
EClinicalMedicine ; 60: 102017, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37396807
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article